Therefore, we evaluated the anti-proliferation effects of a next-generation HSP90AA1 inhibitor, NVP-AUY922 (AUY922), which has high affinity against HSP90AA1 in vitro, for mutant KIT expressing GIST cell in our previous study [14-17]. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.